Sildenafil Analogues for Treatment of Erectile Dysfunction
Journal of Medicinal Chemistry, 2008, Vol. 51, No. 9 2813
and H-5′, J ) 7.2); 7.86–7.92 (m, 2H, H-4′, and H-6′); 12.21 (br
s, 1H, NH); ESI/MS: 555.44 [M + H]+. Anal. (C27H31FN6O4S) C,
H, N.
6.62–7.47 (m, 9H); 12.30 (br s, 1H, NH); ESI/MS: 587.44 [M +
H]+. Anal. (C31H34N6O4S) C, H, N.
5-{2-Ethoxy-5-[(4-(1-piperonyl)piperazinylsulphonyl]phenyl)-
1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-
7-one (6n). It was synthesized from 5a and 1-piperonylpiperazine.
Yield 85%; mp: 193–195 °C. 1H NMR (500 MHz, DMSO) δ: 0.94
(t, 3H, CH2CH2CH3, J ) 7.5 Hz); 1.32 (t, 3H, OCH2CH3, J ) 6.9
Hz); 1.69–1.81 (m, 2H, CH2CH2CH3); 2.49 (t, 2H, CH2CH2CH3, J
) 7.5 Hz); 3.28–3.34 (m, 10H, 4NCH2, CH2); 4.14 (s, 3H, NCH3);
4.20 (q, 2H, OCH2CH3, J ) 6.9 Hz); 5.94 (s, 2H); 6.66–6.79 (m,
3H); 7.36 (d, 1H, H-3′, J ) 9.0 Hz); 7.79–7.81 (m, 2H, H-4′, and
H-6′); 12.30 (br s, 1H, NH); ESI/MS: 595.44 [M + H]+. Anal.
(C28H32N6O6S) C, H, N.
5-{2-Ethoxy-5-[(4-(1-(cyclohexyl))piperazinylsulphonyl]phenyl)-
1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-
7-one (6o). It was synthesized from 5a and 1-(cyclohexyl)
piperazine. Yield 90%; mp: 209–211 °C. 1H NMR (500 MHz,
DMSO) δ: 0.92 (t, 3H, CH2CH2CH3, J ) 7.5 Hz); 1.12 (t, 3H,
OCH2CH3, J ) 6.9 Hz); 1.29–1.32 (m, 10H); 1.65–1.74 (m, 2H,
CH2CH2CH3); 2.49 (t, 2H, CH2CH2CH3, J ) 7.5 Hz); 2.70–2.83
(m, 1H); 3.20–3.60 (m, 8H, 4NCH2); 4.14 (s, 3H, NCH3); 4.20 (q,
2H, OCH2CH3, J ) 6.9 Hz); 7.36 (d, 1H, H-3′, J ) 9.0 Hz);
7.79–7.80 (m, 2H, H-4′, and H-6′); 12.30 (br s, 1H, NH); ESI/MS:
543.44 [M + H]+. Anal. (C27H38N6O4S) C, H, N.
5-{2-Ethoxy-5-[(4-(4-fluorophenyl)piperazinylsulphonyl]phenyl)-
1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-
7-one (6f). It was synthesized from 5a and 4-(fluorophenyl)
piperazine. Yield 85%; mp: 195–197 °C. 1H NMR (500 MHz,
DMSO) δ: 0.94 (t, 3H, CH2CH2CH3, J ) 7.5 Hz); 1.28 (t, 3H,
OCH2CH3, J ) 6.9 Hz); 1.62–1.73 (m, 2H, CH2CH2CH3); 2.49 (t,
2H, CH2CH2CH3, J ) 7.5 Hz); 3.20–3.60 (m, 8H, 4NCH2); 4.14
(s, 3H, NCH3); 4.20 (q, 2H, OCH2CH3, J ) 6.9 Hz); 6.60 (m, 2H,
H-4′, and H-6′); 6.92 (d, 1H, H-3′, J ) 9.0 Hz); 7.08 (t, 2H, H-3′,
and H-5′, J ) 7.2); 7.86–7.92 (m, 2H, H-4′, and H-6′); 12.20 (br
s, 1H, NH); ESI/MS: 555.44 [M + H]+. Anal. (C27H31FN6O4S) C,
H, N.
5-{2-Ethoxy-5-[(4-(2-chlorophenyl))piperazinylsulpho-
nyl]phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo[4,3-
d]pyrimidin-7-one (6g). It was synthesized from 5a and (2-
1
chlorophenyl) piperazine. Yield 65%; mp: 213–215 °C. H NMR
(500 MHz, DMSO) δ: 0.92 (t, 3H, CH2CH2CH3, J ) 7.5 Hz); 1.32
(t, 3H, OCH2CH3, J ) 6.9 Hz); 1.70–1.74 (m, 2H, CH2CH2CH3);
2.49 (t, 2H, CH2CH2CH3, J ) 7.5 Hz); 2.74–3.05 (m, 8H, 4NCH2);
4.14 (s, 3H, NCH3); 4.20 (q, 2H, OCH2CH3, J ) 6.9 Hz); 6.60 (m,
2H, H-4′, and H-6′); 6.92 (d, 1H, H-3′, J ) 9.0 Hz); 7.08 (t, 2H,
H-3′, and H-5′, J ) 7.2); 7.86–7.88 (m, 2H, H-4′, and H-6′); 12.21
(br s, 1H, NH); ESI/MS: 572.44 [M + H]+. Anal. (C27H31ClN6O4S)
C, H, N.
5-{2-Ethoxy-5-[(4-decanoic acid ethyl ester)piperazinylsul-
phonyl]phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo[4,3-
d]pyrimidin-7-one (6p). A mixture of 5-{2-ethoxy-5-[(4-hydroxy-
ethyl)piperazinylsulphonyl]phenyl}-1-methyl-3-N-propyl-1,6-dihydro-
7H-pyrazolo[4,3-d]pyrimidin-7-one (5b) (0.5 g, 1 mmol) and
decanoyl chloride (0.19 g, 1 mmol) in anhydrous chloroform (20
mL) was added; the reaction mixture was introduced into the
reaction vessel, and the desired parameters (microwave, power,
temperature, and time) were set as reported in Table 1. The solvent
was evaporated in vacuo, the residue was dissolved in H2O (50
mL) and brine, and then the solution was washed with ethyl acetate
(70 mL), dried with Na2SO4, and evaporated under vacuum. The
resulting crude residue was purified on silica gel column using
dichloromethane/methanol 15/1 (v/v) as eluent. The product was
6p crystallized as white solid from diethyl ether. Yield (90%); mp:
5-{2-Ethoxy-5-[(4-(3-chlorophenyl))piperazinylsulpho-
nyl]phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo[4,3-
d]pyrimidin-7-one (6h). It was synthesized from 5a and (3-
1
chlorophenyl) piperazine. Yield 77%; mp: 200–202 °C. H NMR
(500 MHz, DMSO) δ: 0.92 (t, 3H, CH2CH2CH3, J ) 7.5 Hz); 1.30
(t, 3H, OCH2CH3, J ) 6.9 Hz); 1.70–1.74 (m, 2H, CH2CH2CH3);
2.49 (t, 2H, CH2CH2CH3, J ) 7.5 Hz); 2.74–3.05 (m, 8H, 4NCH2);
4.14 (s, 3H, NCH3); 4.20 (q, 2H, OCH2CH3, J ) 6.9 Hz); 6.78 (m,
2H, H-4′, and H-6′); 6.91 (d, 1H, H-3′, J ) 9.0 Hz); 7.16 (t, 2H,
H-3′, and H-5′, J ) 7.2); 7.86–7.88 (m, 2H, H-4′, and H-6′); 12.18
(br s, 1H, NH); ESI/MS: 572.44 [M + H]+. Anal. (C27H31ClN6O4S)
C, H, N.
1
5-{2-Ethoxy-5-[(4-(4-chlorophenyl))piperazinylsulpho-
nyl]phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo[4,3-
d]pyrimidin-7-one (6i). It was synthesized from 5a and (4-
149–151 °C. H NMR (500 MHz, DMSO) δ: 0.81–0.93 (m, 6H);
1.16–1.43 (m, 15H); 1.72–1.73 (m, 4H); 2.74–2.86 (m, 6H);
3.20–3.60 (m, 8H, 4NCH2); 4.03–4.20 (m, 5H); 4.20 (q, 2H,
OCH2CH3, J ) 6.9 Hz); 6.92 (d, 1H, H-3′, J ) 9.0 Hz); 7.86–7.92
(m, 2H, H-4′, and H-6′); 12.30 (br s, 1H, NH); ESI/MS: 659.85
[M + H]+. Anal. (C33H50N6O6S) C, H, N.
1
chlorophenyl) piperazine. Yield 66%; mp: 212–214 °C. H NMR
(500 MHz, DMSO) δ: 0.92 (t, 3H, CH2CH2CH3, J ) 7.5 Hz); 1.32
(t, 3H, OCH2CH3, J ) 6.9 Hz); 1.70–1.74 (m, 2H, CH2CH2CH3);
2.49 (t, 2H, CH2CH2CH3, J ) 7.5 Hz); 2,74–3,02 (m, 8H, 4NCH2);
4,10 (s, 3H, NCH3); 4,21 (q, 2H, OCH2CH3, J ) 6.9 Hz); 6.89 (m,
2H, H-4′, and H-6′); 6.92 (d, 1H, H-3′, J ) 9.0 Hz); 7.37 (t, 2H,
H-3′, and H-5′, J ) 7.2); 7.83–7.86 (m, 2H, H-4′, and H-6′); 12.21
(br s, 1H, NH); ESI/MS: 572.44 [M + H]+. Anal. (C27H31ClN6O4S)
C, H, N.
5-{2-Ethoxy-5-[(4-chlorobutyric acid ethyl ester)piperazinyl-
sulphonyl] phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyra-
zolo[4,3-d]pyrimidin-7-one (5c). A mixture of 5-{2-ethoxy-5-[(4-
hydroxyethyl)piperazinylsulphonyl]phenyl}-1-methyl-3-N-propyl-
1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one (5b) (0.5 g, 1
mmol), chlorobutyryl chloride (0.1 g mmol) in anhydrous chloro-
form (20 mL), and a solution of saturated NaHCO3 (10 mL) was
stirred at 0 °C for 2 h. The solvent was evaporated under vacuum,
the residue dissolved in H2O (50 mL) and brine, and then the
organic phase was separated, dried over anhydrous Na2SO4, and
evaporated under vacuum. (90%); mp: 169–170 °C.
5-{2-Ethoxy-5-[(4-(4-nitrophenyl))piperazinylsulphonyl]phenyl)-
1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-
7-one (6l). It was synthesized from 5a and (4-nitrophenyl)
piperazine and eluted with dichloromethane/methanol 9/1 (v/v).
Yield 90%; mp: 221–223 °C. 1H NMR (500 MHz, DMSO) δ: 0.91
(t, 3H, CH2CH2CH3, J ) 7.5 Hz); 1.27 (t, 3H, OCH2CH3, J ) 6.9
Hz); 1.68–1.73 (m, 2H, CH2CH2CH3); 2.49 (t, 2H, CH2CH2CH3, J
) 7.5 Hz); 2.71–2.74 (m, 8H, 4NCH2); 3.32 (s, 3H, NCH3); 4.14
(q, 2H, OCH2CH3, J ) 6.9 Hz); 6.98 (m, 2H, H-4′, and H-6′);
7.31 (d, 1H, H-3′, J ) 9.0 Hz); 7.81 (t, 2H, H-3′, and H-5′, J )
7.2); 8.01–8.02 (m, 2H, H-4′, and H-6′); 12.21 (br s, 1H, NH);
ESI/MS: 572.44 [M + H]+. Anal. (C27H31N7O6S) C, H, N.
5-{2-Ethoxy-5-[4-(1-naphthyl)piperazinylsulphonyl]phenyl)-
1-methyl-3-N-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-
7-one (6m). It was synthesized from 5a and 1-naphthylpiperazine.
Yield 89%; mp: 260–262 °C. 1H NMR (500 MHz, DMSO) δ: 0.94
(t, 3H, CH2CH2CH3, J ) 7.5 Hz); 1.32 (t, 3H, OCH2CH3, J ) 6.9
Hz); 1.69–1.81 (m, 2H, CH2CH2CH3); 2.49 (t, 2H, CH2CH2CH3, J
) 7.5 Hz); 3.20–3.60 (m, 8H, 4NCH2); 4.14 (s, 3H, NCH3); 4.20
(q, 2H, OCH2CH3, J ) 6.9 Hz); 6.92 (d, 1H, H-3′, J ) 9.0 Hz);
5-{2-Ethoxy-5-[(4-nitro-butyric acid ethyl ester)piperazinyl-
sulphonyl] phenyl)-1-methyl-3-N-propyl-1,6-dihydro-7H-pyra-
zolo[4,3-d] pyrimidin-7-one (6q). A mixture of 5c (0.6 g, 1 mmol)
with AgNO3 (0.34 g, 2 mmol) in acetonitrile (30 mL) was stirred
at reflux under light exclusion. The mixture was filtered on Celite,
the solvent was evaporated in vacuo, the residue was dissolved in
H2O (50 mL) and brine, and then the organic phase was separated,
dried with Na2SO4, and evaporated in vacuo. The resulting crude
residue was purified on silica gel column using diethyl ether/ethanol,
1
8:2 (v/v) as eluent. Yield 90%; mp: 153–155 °C. H NMR (500
MHz, DMSO) δ: 0.92 (t, 3H, CH2CH2CH3, J ) 7.5 Hz); 1.32 (t,
3H, OCH2CH3, J ) 6.9 Hz); 1.72–1.73 (m, 2H, CH2CH2CH3);
1.85–1.87 (m, 2H); 2.35–2.37 (m, 4H); 2.49–2.52 (m, 8H, 4NCH2);
2.74–2.77 (m, 2H); 3.30–3.31 (m, 2H); 4.05–4.19 (m, 5H); 4.20
(q, 2H, OCH2CH3, J ) 6.9 Hz); 6.92 (d, 1H, H-3′, J ) 9.0 Hz);